PAX8 and acute kidney injury: We employed the selective inhibitor of YAP1/TEAD transcriptional activity CA334,35 and started treatment of Pax8/FUCCI2aR and non-induced (WT) mice 4 days after nephrotoxic AKI, i.e., after recovery of function loss had occurred (Fig. 9a).